跳至主要内容
临床试验/JPRN-UMIN000010397
JPRN-UMIN000010397已完成未知

Effect of combination therapy with DPP-4 inhibitor and omega 3-fatty acid on glycemic control in type2 diabetes with dyslipidemia - Effect of combination therapy with DPP-4 inhibitor and omega 3-fatty acid on glycemic control

Yokohama City University Medical Center0 个研究点目标入组 150 人开始时间: 2013年4月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)severe ketosis, diabetic coma within 6 months 2)present or history of CHF 3)severe infection, before operation, severe trauma 4)severe hepatic dysfunction 5)or severe renal dysfunction (SCr:more than 2.0mg/dl or eGFR less than 30) 6)pregnacy 7)Allergy for DPP-4 inhibitores or omega 3 fatty acid 8)Patients judged by the investigator to be ineligible for some other reason 9)Changes of doses with oral hypoglycemic agents or antihyperelipidemic drugs during the study

研究者

相似试验